
BioLife Solutions BLFS
$ 38.61
3.51%
Country |
|
IPO year |
- |
Industry |
Medical instruments |
Stock Exchange |
NASDAQ GLOBAL |
Shares |
47.8 M |
Market Cap[1] |
$ 1.84 B |
EBITDA (LTM) |
$ -14.3 M |
P/E (LTM) |
-391.666667 |
P/S (LTM) |
17.495607 |
EPS (LTM) |
-0.09 |
Other stocks of industry "Medical instruments"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
|
AtriCure
ATRC
|
$ 56.07 | 0.84 % | $ 2.68 B | Nasdaq Global Market,SPB | ||
|
InfuSystem Holdings
INFU
|
$ 13.4 | 2.43 % | $ 277 M | NYSE American | ||
|
Alcon
ALC
|
$ 66.18 | 0.44 % | $ 32.6 B | NYSE | ||
|
NeuroMetrix
NURO
|
- | 5.05 % | $ 9.02 M | Nasdaq Global Select Market | ||
|
Milestone Scientific
MLSS
|
$ 0.33 | 1.01 % | $ 27.1 M | NYSE American | ||
|
Merit Medical Systems
MMSI
|
$ 89.2 | 0.33 % | $ 5.28 B | Nasdaq Global Select Market,SPB | ||
|
Atrion Corporation
ATRI
|
- | - | $ 810 M | Nasdaq Global Select Market,SPB | ||
|
Becton, Dickinson and Company
BDX
|
$ 191.75 | 0.9 % | $ 55.2 B | NYSE,SPB | ||
|
Nephros
NEPH
|
$ 3.65 | 3.99 % | $ 38.7 M | Nasdaq Global Select Market | ||
|
Envista Holdings Corporation
NVST
|
$ 22.9 | 0.43 % | $ 3.85 B | NYSE | ||
|
electroCore
ECOR
|
$ 7.85 | 0.84 % | $ 66.6 K | Nasdaq Global Select Market | ||
|
Baxter International
BAX
|
$ 25.28 | 0.04 % | $ 13 B | NYSE,SPB | ||
|
Pro-Dex
PDEX
|
$ 58.26 | 0.33 % | $ 188 B | Nasdaq Global Select Market | ||
|
Pulse Biosciences
PLSE
|
$ 44.43 | 0.09 % | $ 2.99 B | Nasdaq Global Select Market | ||
|
Repligen Corporation
RGEN
|
$ 175.42 | 0.23 % | $ 9.86 M | Nasdaq Global Select Market,SPB | ||
|
Retractable Technologies
RVP
|
$ 0.58 | 0.02 % | $ 17.4 M | NYSE American | ||
|
STAAR Surgical Company
STAA
|
$ 21.27 | 1.92 % | $ 1.05 B | Nasdaq Global Market,SPB | ||
|
STERIS plc
STE
|
$ 222.66 | 0.96 % | $ 21.9 B | NYSE,SPB | ||
|
Stereotaxis
STXS
|
$ 1.01 | 0.48 % | $ 91.9 M | NYSE American | ||
|
Utah Medical Products
UTMD
|
$ 74.51 | 0.12 % | $ 241 M | Nasdaq Global Select Market | ||
|
Glaukos Corporation
GKOS
|
$ 164.84 | 0.06 % | $ 9.43 B | NYSE,SPB | ||
|
Intuitive Surgical
ISRG
|
$ 426.7 | 0.14 % | $ 152 B | Nasdaq Global Select Market,SPB | ||
|
West Pharmaceutical Services
WST
|
$ 384.02 | 0.26 % | $ 27.8 B | NYSE,SPB | ||
|
DENTSPLY SIRONA
XRAY
|
$ 8.57 | 0.34 % | $ 1.71 B | Nasdaq Global Select Market,SPB | ||
|
AngioDynamics
ANGO
|
$ 11.24 | 4.8 % | $ 467 M | Nasdaq Global Select Market | ||
|
Haemonetics Corporation
HAE
|
$ 118.28 | 0.47 % | $ 5.58 B | NYSE,SPB | ||
|
Repro Med Systems
KRMD
|
$ 3.0 | 0.17 % | $ 139 M | Nasdaq Capital Market | ||
|
iRhythm Technologies
IRTC
|
$ 108.66 | 0.4 % | $ 3.48 B | Nasdaq Global Select Market,SPB | ||
|
LeMaitre Vascular
LMAT
|
$ 80.82 | 0.65 % | $ 1.83 B | Nasdaq Global Market,SPB | ||
|
Harvard Bioscience
HBIO
|
$ 8.09 | 0.75 % | $ 359 M | Nasdaq Global Market | ||
|
ICU Medical
ICUI
|
$ 162.99 | 0.28 % | $ 4.02 B | Nasdaq Global Select Market,SPB | ||
|
ResMed
RMD
|
$ 238.97 | 2.89 % | $ 34.8 B | NYSE,SPB | ||
|
OraSure Technologies
OSUR
|
$ 3.61 | 0.52 % | $ 265 M | Nasdaq Global Select Market,SPB | ||
|
Teleflex Incorporated
TFX
|
$ 130.43 | 1.72 % | $ 5.82 B | NYSE,SPB | ||
|
CRH Medical Corporation
CRHM
|
- | - | $ 282 M | NYSE American | ||
|
Cantel Medical Corp.
CMD
|
- | -1.18 % | $ 3.4 B | NYSE | ||
|
The Cooper Companies
COO
|
$ 57.94 | 0.94 % | $ 11.5 B | NYSE,SPB | ||
|
Microbot Medical
MBOT
|
$ 0.95 | 2.43 % | $ 43.5 M | Nasdaq Global Select Market | ||
|
Luminex Corporation
LMNX
|
- | - | $ 1.75 B | Nasdaq Global Select Market | ||
|
Akers Biosciences, Inc.
AKER
|
- | -9.52 % | $ 20.6 M | Nasdaq Capital Market | ||
|
Antares Pharma, Inc.
ATRS
|
- | - | $ 955 M | Nasdaq Capital Market | ||
|
Hill-Rom Holdings, Inc.
HRC
|
- | -0.05 % | $ 10.3 B | NYSE,SPB | ||
|
Varian Medical Systems, Inc.
VAR
|
- | -0.02 % | $ 16.3 B | NYSE | ||
|
Ekso Bionics Holdings
EKSO
|
- | - | $ 28.6 M | Nasdaq Capital Market | ||
|
Isoray
ISR
|
- | 0.03 % | $ 108 M | NYSE American | ||
|
Masimo Corporation
MASI
|
- | - | $ 9.59 B | Nasdaq Global Select Market,SPB | ||
|
Predictive Oncology
POAI
|
- | - | $ 31.1 M | Nasdaq Capital Market |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.